IPO Boutique Research, Color & More Information for Subscribers
This content is restricted to IPO Boutique Subscribers Username or E-mail: Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Acadia Pharmaceuticals, Inc. Symbol: ACAD Price: Last trade $35.23 Trade Date: 8/10 Shares: 5.7 million Underwriter(s) J.P. Morgan, Goldman Sachs, BofA[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Loxo Oncology, Inc. Symbol: LOXO Price: Last trade $22.44 Description: Re-offer range $21.50-$22.00 Trade Date: 5/12 Shares: 1.3 million Underwriter(s) Citi,[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Kite Pharma, Inc. Symbol: KITE Price: Last trade $74.85 Trade Date: 12/10 Shares: 3.34 million Underwriter(s) Jefferies, Citigroup, Cowen & Co.,[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: SoTHERLY Hotels Inc. Symbol: SOHO Price: Last trade $8.25 Trade Date: wk of 6/22 Shares: 3 million Underwriter(s) Sandler O’Neill, JMP[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Mylan N.V. Symbol: MYL Price: Last trade $61.63 Trade Date: 4/1 Shares: 35 million Underwriter(s) Morgan Stanley, Goldman Sachs Rating=Subscription Needed[…]